Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/117313) titled 'A Study to Evaluate the Safety of KEYTRUDA in Combination with Standard Cancer Treatment in Patients with Different Types of Cancer in India' on Sept. 9.
Study Type: Interventional
Study Design:
Other Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Open Label
Primary Sponsor: MSD Pharmaceuticals Private Limited
Condition:
Health Condition 1: C221- Intrahepatic bile duct carcinoma
Health Condition 2: C160- Malignant neoplasm of cardia
Health Condition 3: C539- Malignant neoplasm of cervix uteri, unspecified
Health Conditio...